QHSLab, Inc.
QHSLab, Inc.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | |||||||||||||||||
Assets Current | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Prepaid Expense Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Assets Noncurrent | |||||||||||||||||
Capitalized Software Development Costs For Softwar… | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Capitalized Computer Software Net | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | |||||
Finite Lived Intangible Assets Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Assets | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Other Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Loans Payable Current | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | - | |||||
Short Term Borrowings | - | - | - | - | - | - | - | - | - | - | 1 | 0 | |||||
Convertible Notes Payable Current | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Long Term Loans Payable | - | - | 0 | - | - | - | - | 0 | - | - | - | - | |||||
Liabilities Noncurrent | |||||||||||||||||
Liabilities Noncurrent | - | - | 0 | - | - | - | - | 0 | - | - | - | - | |||||
Liabilities | 0 | 0 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Additional Paid In Capital | 6 | 6 | 6 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | |||||
Stockholders Equity | 2 | 2 | 2 | -1 | -1 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | |||||
Retained Earnings Accumulated Deficit | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | |||||
Liabilities And Stockholders Equity | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | - | 0.25 | 0.25 | |||||
Common Stock Shares Authorized | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Issued | 15 | 15 | 15 | 11 | 11 | 11 | 11 | 10 | 10 | 10 | 10 | 9 | |||||
Shares Outstanding | 15 | 15 | 15 | 11 | 11 | 11 | 11 | 10 | 10 | 10 | 10 | 9 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.22% | -41.11% | -42.22% | - | - | - | - | - | - | - | - | - |
| 2025 | 17.65% | 23.53% | 28.24% | -5.29% | 7.41% | -13.23% | 76.83% | 448.78% | 323.17% | 28.07% | -8.77% | -40.53% |
| 2024 | 150.00% | 220.00% | 100.00% | -32.67% | -20.00% | 16.00% | 90.22% | 236.96% | 96.74% | -32.00% | -4.80% | -20.00% |
| 2023 | - | - | - | - | - | - | -32.35% | 164.71% | 194.12% | -17.00% | 18.00% | 150.00% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.82 | 1.68 | 1.96 | 0.18 | 0.16 | 0.14 | 0.17 | 0.17 | 0.12 | 0.11 | 0.08 | 0.09 | |||||
| Quick Ratio | 1.76 | 1.53 | 1.84 | 0.16 | 0.13 | 0.11 | 0.15 | 0.14 | 0.11 | 0.09 | 0.06 | 0.07 | |||||
| Working Capital | 307.11K | 251.05K | 433.15K | -1.92M | -1.97M | -1.93M | -1.99M | -1.74M | -1.84M | -1.87M | -1.90M | -1.86M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.24 | 0.24 | 0.34 | -3.84 | -3.65 | -3.82 | -3.96 | -6.26 | -5.41 | -5.53 | -5.48 | -6.81 | |||||
| Interest Coverage TTM | 0.68 | 0.27 | 0.55 | 0.30 | 0.30 | 0.36 | 0.44 | 0.59 | -0.26 | -0.55 | -1.04 | -0.65 | |||||
| Debt Ratio | 0.19 | 0.19 | 0.25 | 1.35 | 1.38 | 1.35 | 1.34 | 1.19 | 1.23 | 1.22 | 1.22 | 1.17 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.66 | 1.56 | 1.36 | 1.49 | 1.42 | 1.35 | 1.22 | 1.04 | 0.91 | 0.86 | 0.77 | 0.70 | |||||
| Days Sales Outstanding TTM | 29.71 | 26.06 | 26.22 | 28.51 | 21.09 | 25.98 | 22.90 | 28.24 | 26.39 | 24.47 | 15.43 | 18.98 | |||||
| Receivables Turnover TTM | 12.29 | 14.01 | 13.92 | 12.80 | 17.31 | 14.05 | 15.94 | 12.93 | 13.83 | 14.92 | 23.66 | 19.23 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 0.02 | 0.03 | 0.02 | -0.02 | -0.03 | -0.03 | -0.03 | -0.00 | -0.02 | -0.03 | -0.05 | -0.06 | |||||
| Free Cash Flow Per Share TTM | -0.01 | 0.00 | 0.02 | 0.01 | 0.01 | 0.00 | 0.01 | -0.00 | 0.00 | -0.01 | -0.02 | -0.01 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 67.70% | 66.73% | 67.27% | 66.37% | 66.34% | 65.61% | 63.69% | 62.37% | 59.52% | 57.77% | 56.32% | 54.25% | |||||
| Operating Profit Margin TTM | 2.74% | 1.76% | 4.88% | 6.46% | 6.68% | 7.87% | 9.65% | 4.63% | -2.48% | -6.85% | -17.04% | -24.78% | |||||
| Net Profit Margin TTM | 17.37% | 15.61% | 16.99% | -14.80% | -15.30% | -14.00% | -12.16% | -3.20% | -11.81% | -19.05% | -33.24% | -43.91% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 24.61% | 21.25% | 26.26% | 43.55% | 50.09% | 48.16% | 51.31% | 33.73% | 24.60% | 24.51% | 13.34% | 4.31% | |||||
| Net Income Growth (1Y) | -241.50% | -235.21% | -276.45% | 563.52% | 94.44% | 8.83% | -44.65% | -90.25% | -76.93% | -70.52% | -52.98% | -43.07% | |||||
| EPS Growth (1Y) | -206.19% | -200.66% | -260.69% | 517.17% | 76.12% | -3.94% | -49.34% | -91.35% | -78.97% | -72.19% | -55.07% | -44.58% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 7.60 | 21.41 | 14.97 | -5.54 | -6.40 | -8.73 | -9.84 | -21.60 | -13.09 | -2.92 | -1.81 | -0.79 | |||||
| P/B TTM | 2.56 | 6.10 | 4.21 | -3.51 | -3.68 | -4.73 | -4.20 | -3.76 | -6.48 | -2.25 | -2.26 | -1.59 | |||||
| P/S TTM | 1.32 | 3.34 | 2.54 | 0.82 | 0.98 | 1.22 | 1.20 | 0.69 | 1.55 | 0.56 | 0.60 | 0.35 | |||||
| Market Cap | 3.98M | 9.28M | 6.85M | 2.14M | 2.37M | 2.80M | 2.55M | 1.26M | 2.49M | 859.38K | 847.51K | 475.09K | |||||
| Enterprise Value | 3.67M | 8.95M | 6.32M | 3.57M | 3.78M | 4.34M | 4.12M | 2.87M | 4.06M | 2.51M | 3.12M | 2.08M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -107.43K | 27.43K | 178.12K | 135.14K | 75.96K | 36.32K | 142.44K | -47.78K | 21.87K | -104.76K | -159.63K | -94.25K | |||||
| Net Debt | -317.39K | -325.21K | -530.59K | 1.42M | 1.41M | 1.54M | 1.57M | 1.61M | 1.56M | 1.65M | 2.28M | 1.61M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
QHSLab, Inc. (USAQ) — SEC Financial Statements & Analysis
QHSLab, Inc. (USAQ) is a surgical & medical instruments & apparatus company, incorporated in NV. QHSLab, Inc. trades on OTC as: USAQ. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), QHSLab, Inc. reported a 24.61% year-over-year revenue growth, a Gross Profit Margin of 67.70% (TTM), a Debt-to-Equity ratio of 0.24x, a Price-to-Sales (P/S) ratio of 1.32x (TTM), a Price-to-Book (P/B) ratio of 2.56x (TTM), at a market cap of $3.98M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 24.61%
- Gross Profit Margin TTM
- 67.70%
- Debt To Equity
- 0.24x
- P/S TTM
- 1.32x
- P/B TTM
- 2.56x
- Market Cap
- $3.98M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is QHSLab, Inc. in?
QHSLab, Inc. (USAQ) operates in the Surgical & Medical Instruments & Apparatus industry.
What is USAQ's market cap?
QHSLab, Inc. (USAQ) has a market capitalization of $3.98M as of 2026-06-30.
What is USAQ's P/E ratio?
QHSLab, Inc. (USAQ)'s trailing twelve month P/E ratio is 7.60x as of 2026-06-30.
What exchange does USAQ trade on?
QHSLab, Inc. (USAQ) trades on the OTC.
Where is QHSLab, Inc. incorporated?
QHSLab, Inc. is incorporated in NV.